A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up

European Journal of Cancer

Volumn 47, Issue 13, 2011, Pages 1977-1989

  Livingstone, Elisabeth ^a   Windemuth Kieselbach, Christine ^b   Eigentler, Thomas K ^c   Rompel, Rainer ^d   Trefzer, Uwe ^e   Nashan, Dorothee ^f   Rotterdam, Sebastian ^g   Ugurel, Selma ^h   Schadendorf, Dirk ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ALCEDIS GMBH   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Clinical Center of Kassel   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g ST JOSEF HOSPITAL   (Germany)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Clinical practice assessment; Cost effectiveness; Melanoma; Population based analysis; Prospective study

Indexed keywords

DACARBAZINE; INTERFERON; PEGINTERFERON;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE SCINTISCANNING; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; COMPLETE LYMPH NODE DISSECTION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE COST; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SENTINEL LYMPH NODE BIOPSY; THORAX RADIOGRAPHY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GERMANY; GUIDELINE ADHERENCE; HUMANS; LONGITUDINAL STUDIES; MALE; MELANOMA; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051904163     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.04.029     Document Type: Article

References (50)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
2. P. Saiag, L. Bosquet, and B. Guillot Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report Eur J Dermatol 17 4 2007 325 331 (Pubitemid 47051549)
3. D.G. Coit, R. Andtbacka, and C.K. Bichakjian Melanoma J Natl Compr Canc Netw 7 3 2009 Mar 250 275
4. R. Dummer, R. Panizzon, P.H. Bloch, and G. Burg Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma Dermatology 210 1 2005 39 44 (Pubitemid 39656718)
5. C. Garbe, D. Schadendorf, and W. Stolz Short German guidelines: malignant melanoma J Dtsch Dermatol Ges 6 Suppl. 1 2008 S9 S14
6. J.R. Marsden, J.A. Newton-Bishop, and L. Burrows Revised U.K. guidelines for the management of cutaneous melanoma 2010 Br J Dermatol. 163 2 2010 238 256
7. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Wellington 2008 updated 31.10.2008. .
8. J.J. van Everdingen, H.J. van der Rhee, and C.C. Koning Guideline 'Melanoma' (3rd revision) Ned Tijdschr Geneeskd. 149 33 2005 1839 1843
9. M.B. Lens, M. Dawes, J.A. Newton-Bishop, and T. Goodacre Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice Br J Plast Surg. 55 5 2002 372 375 (Pubitemid 34993880)
10. J. Haniff, E. de Vries, A.T. Claassen, C.W. Looman, C. van Berlo, and J.W. Coebergh Non-compliance with the re-excision guidelines for cutaneous melanoma in The Netherlands does not influence survival Eur J Surg Oncol 32 1 2006 85 89 (Pubitemid 43103994)
11. F. Grange, F. Vitry, and F. Granel-Brocard Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France Arch Dermatol 144 5 2008 629 636 (Pubitemid 351724423)
12. U.R. Hengge, A. Wallerand, A. Stutzki, and N. Kockel Cost-effectiveness of reduced follow-up in malignant melanoma J Dtsch Dermatol Ges 5 10 2007 Oct 898 907 (Pubitemid 47546372)
13. U. Hofmann, M. Szedlak, W. Rittgen, E.G. Jung, and D. Schadendorf Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival Br J Cancer 87 2 2002 151 157
14. U. Leiter, A.A. Marghoob, and K. Lasithiotakis Costs of the detection of metastases and follow-up examinations in cutaneous melanoma Melanoma Res 19 1 2009 50 57
15. J.L. Erickson, J.M. Velasco, and T.J. Hieken Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables Ann Surg Oncol 15 4 2008 1211 1217
16. J.W. Kelly, M.A. Henderson, and V.J. Thursfield The management of primary cutaneous melanoma in Victoria in 1996 and 2000 Med J Aust 187 9 2007 511 514
17. J.M. Thomas, J. Newton-Bishop, and R. A'Hern Excision margins in high-risk malignant melanoma N Engl J Med. 350 8 2004 757 766 (Pubitemid 38209645)
18. P.J. Heenan Histopathologic excision margin affects local recurrence rate: Analysis of 2681 patients with melanoma < or = 2 mm thick Ann Surg. 243 4 2006 569 [author reply -70]
19. C.M. Balch, S. Soong, and M.I. Ross Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (10 to 4.0 mm). Intergroup Melanoma Surgical Trial Ann Surg Oncol 7 2 2000 87 97 (Pubitemid 30164676)
20. G. Cohn-Cedermark, L.E. Rutqvist, and R. Andersson Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 08-2.0 mm Cancer 89 7 2000 1495 1501
21. D. Khayat, O. Rixe, and G. Martin Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 21-mm thick) Cancer 97 8 2003 1941 1946
22. U. Veronesi, and N. Cascinelli Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma Arch Surg 126 4 1991 438 441
23. A. Testori, P. Rutkowski, and J. Marsden Surgery and radiotherapy in the treatment of cutaneous melanoma Ann Oncol. 20 Suppl. 6 2009 vi22 vi29
24. C. Garbe, K. Peris, and A. Hauschild Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline Eur J Cancer 46 2 2010 Jan 270 283
25. M.B. Lens, P. Nathan, and V. Bataille Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials Arch Surg. 142 9 2007 885 891 discussion 91-3 (Pubitemid 47437312)
26. Sladden MJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009(4):CD004835.
27. K.Y. Bilimoria, C.M. Balch, and J.D. Wayne Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States J Clin Oncol 27 11 2009 1857 1863
28. J.N. Cormier, Y. Xing, and M. Ding Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy J Clin Oncol 23 25 2005 6054 6062
29. K.B. Stitzenberg, N.E. Thomas, L.M. Beskow, and D.W. Ollila Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma J Surg Oncol. 93 2 2006 100 107 [discussion 7-8] (Pubitemid 43235254)
30. K.M. McMasters, D.S. Reintgen, and M.I. Ross Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement J Clin Oncol 19 11 2001 2851 2855 (Pubitemid 32538194)
31. B.E. Saltman, I. Ganly, and S.G. Patel Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma Head Neck 32 12 2010 1686 1692
32. D.L. Morton, J.F. Thompson, and A.J. Cochran Sentinel-node biopsy or nodal observation in melanoma N Engl J Med. 355 13 2006 1307 1317 (Pubitemid 44465459)
33. Klode J, Poeppel T, Boy C, et al. Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol. 2010 [Epub ahead of print].
34. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 36 2009 6199 6206
35. L. Vermeeren, F. Van der Ent, P. Sastrowijoto, and K. Hulsewe Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value Eur J Dermatol 20 1 2010 30 34
36. A.C. van Akkooi, J.H. de Wilt, and C. Verhoef Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol 17 10 2006 1578 1585 (Pubitemid 44542045)
37. A.C. van Akkooi, Z.I. Nowecki, and C. Voit Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes Ann Surg 248 6 2008 949 955
38. A. Govindarajan, D.M. Ghazarian, D.R. McCready, and W.L. Leong Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse Ann Surg Oncol 14 2 2007 906 912 (Pubitemid 46175342)
39. R.P. Scheri, R. Essner, R.R. Turner, X. Ye, and D.L. Morton Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma Ann Surg Oncol 14 10 2007 2861 2866 (Pubitemid 47460638)
40. S. Negrier, P. Saiag, and B. Guillot Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report) Bull Cancer 93 4 2006 371 384 (Pubitemid 43742486)
41. G.M. Zartman, M.R. Thomas, and W.A. Robinson Metastatic disease in patients with newly diagnosed malignant melanoma J Surg Oncol 35 3 1987 163 164 (Pubitemid 17105305)
42. K.M. Acland, C. Healy, and E. Calonje Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma J Clin Oncol 19 10 2001 2674 2678 (Pubitemid 32441372)
43. A. Ardizzoni, A. Grimaldi, L. Repetto, M. Bruzzone, M.R. Sertoli, and R. Rosso Stage I-II melanoma: the value of metastatic work-up Oncology 44 2 1987 87 89 (Pubitemid 17059801)
44. P.A. Kersey, N.A. Iscoe, and J.A. Gapski The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br J Surg 72 8 1985 Aug 614 617 (Pubitemid 15047613)
45. T. Khansur, J. Sanders, and S.K. Das Evaluation of staging workup in malignant melanoma Arch Surg. 124 7 1989 847 849 (Pubitemid 19181034)
46. M.H. Terhune, N. Swanson, and T.M. Johnson Use of chest radiography in the initial evaluation of patients with localized melanoma Arch Dermatol 134 5 1998 569 572 (Pubitemid 28222309)
47. U. Oelschlaegel, B. Mohr, and M. Schaich HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia Cytometry B Clin Cytom 76 5 2009 321 327
48. L. Martini, P. Brandani, C. Chiarugi, and U.M. Reali First recurrence analysis of 840 cutaneous melanomas: a proposal for a follow-up schedule Tumori. 80 3 1994 188 197 (Pubitemid 24266152)
49. W.H. McCarthy, H.M. Shaw, J.F. Thompson, and G.W. Milton Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study Surg Gynecol Obstet 166 6 1988 497 502
50. N. Iscoe, P. Kersey, and J. Gapski Predictive value of staging investigations in patients with clinical stage I malignant melanoma Plast Reconstr Surg 80 2 1987 233 239 (Pubitemid 17152456)